Learn how healthcare organizations are addressing the impending physician shortage caused by retirements, and the financial impact of not replacing vacant role.

In other words, for those looking for "forever stocks," it's not a bad idea to look in this sector. And even with a modest sum -- such as $200 -- we can find excellent healthcare corporations to ...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.

The "Sarcopenia - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth analysis of the current developments and future prospects in the ...